Wells Fargo & Company Arcturus Therapeutics Holdings Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 61,879 shares of ARCT stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,879
Previous 72,786 14.99%
Holding current value
$1.05 Million
Previous $1.77 Million 18.96%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$18.08 - $25.38 $197,198 - $276,819
-10,907 Reduced 14.99%
61,879 $1.44 Million
Q2 2024

Aug 13, 2024
BUY
$24.35 - $44.39 $27,466 - $50,071
1,128 Added 1.57%
72,786 $1.77 Million
Q1 2024

May 10, 2024
SELL
$31.23 - $42.99 $41,036 - $56,488
-1,314 Reduced 1.8%
71,658 $2.42 Million
Q4 2023

Feb 09, 2024
SELL
$17.71 - $32.97 $668,428 - $1.24 Million
-37,743 Reduced 34.09%
72,972 $2.3 Million
Q3 2023

Nov 13, 2023
SELL
$25.44 - $37.35 $1.09 Million - $1.6 Million
-42,880 Reduced 27.92%
110,715 $2.83 Million
Q2 2023

Aug 15, 2023
SELL
$23.94 - $32.36 $168,609 - $227,911
-7,043 Reduced 4.38%
153,595 $4.41 Million
Q1 2023

May 12, 2023
BUY
$14.72 - $23.97 $647,915 - $1.06 Million
44,016 Added 37.74%
160,638 $3.85 Million
Q4 2022

Feb 13, 2023
SELL
$14.14 - $23.06 $956,797 - $1.56 Million
-67,666 Reduced 36.72%
116,622 $1.98 Million
Q3 2022

Nov 14, 2022
BUY
$13.05 - $22.13 $106,213 - $180,116
8,139 Added 4.62%
184,288 $2.73 Million
Q2 2022

Aug 12, 2022
BUY
$12.26 - $31.17 $239,437 - $608,750
19,530 Added 12.47%
176,149 $2.77 Million
Q1 2022

May 16, 2022
BUY
$17.64 - $39.57 $628,425 - $1.41 Million
35,625 Added 29.44%
156,619 $4.22 Million
Q4 2021

Feb 14, 2022
SELL
$34.2 - $47.56 $631,434 - $878,100
-18,463 Reduced 13.24%
120,994 $4.48 Million
Q3 2021

Nov 15, 2021
BUY
$27.88 - $58.25 $592,143 - $1.24 Million
21,239 Added 17.97%
139,457 $6.66 Million
Q2 2021

Aug 16, 2021
BUY
$25.79 - $42.11 $260,117 - $424,721
10,086 Added 9.33%
118,218 $4 Million
Q1 2021

May 13, 2021
SELL
$38.75 - $86.92 $1.29 Million - $2.89 Million
-33,240 Reduced 23.51%
108,132 $4.47 Million
Q4 2020

Feb 09, 2021
BUY
$34.61 - $123.66 $2.26 Million - $8.08 Million
65,321 Added 85.89%
141,372 $6.13 Million
Q3 2020

Nov 05, 2020
BUY
$37.49 - $63.19 $410,627 - $692,120
10,953 Added 16.83%
76,051 $3.26 Million
Q2 2020

Aug 13, 2020
BUY
$12.66 - $58.27 $623,365 - $2.87 Million
49,239 Added 310.48%
65,098 $3.04 Million
Q1 2020

May 14, 2020
BUY
$9.31 - $18.26 $147,647 - $289,585
15,859 New
15,859 $216,000

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $449M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email